Shanghai Enkai Cell Technology Co., Ltd.
PrivateLast Round
VC Round
Jul 9, 2025
Total Funding Raised
$15M
Company Overview
Shanghai Enkai Cell Technology Co., Ltd. is a biotechnology company that develops innovative NK (Natural Killer) cell therapies for the treatment of tumors and other major clinical diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Enkai Cell Technology Co., Ltd. Comparables
Compare Shanghai Enkai Cell Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NK:IO | 84% | |
| Neukio Biotherapeutics | 83% | |
| Indapta Therapeutics | 83% | |
Shanghai Enkai Cell Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 9, 2025 | ||||
| VC Round | Nov 22, 2024 | ||||
| VC Round | Jun 3, 2023 | ||||
| Series A | Jul 1, 2022 | ||||
| Angel | Nov 19, 2021 |
Shanghai Enkai Cell Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing Fangfu Venture Capital Management | VC Round |
| 乔景资本 (QJ Capital) | Series A |
| Huagai Capital | Series A |
| Unifortune | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2023
Raised a VC Round with Beijing Fangfu Venture Capital Management.
- Jul 1, 2022
$15M round led by Huagai Capital
Shanghai Enkai Cell Technology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Enkai Cell Technology Co., Ltd.'s valuation, stock price, and market status.